Keck Medical Center of USC
Keck Medical Center of USC
Los Angeles, California, United States21 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Learn More About the Long-Term Safety and Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) or Microvascular Inflammation (MVI) (TRANSCEND/TRANSPIRE LTE) | Antibody-mediated Rejection; Microvascular Inflammation | Enrolling by invitation | Phase 3 | 2026-10-09 | NCT07444489 | |
| Telerehabilitation In The Home After Stroke | brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2026-10-09 | NCT06682429 | |
| Alleviant ALLAY-HFrEF Study | cardiovascular disorder, heart disorder, heart failure | Recruiting | Not applicable | 2026-10-06 | NCT06812533 | |
| GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study | Acute Aortic Syndrome, Aneurysm, Aneurysm, Aortic Arch, Aortic Dissection, Dissection, Aortic Arch, Dissection, Blood Vessel, Dissection, Thoracic Aorta, aortic aneurysm, aortic disorder, cardiovascular disorder, thoracic aortic aneurysm, vascular disorder | Recruiting | Not applicable | 2026-10-05 | NCT07166133 | |
| Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States | Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease, substance-related disorder | Recruiting | Phase 2 | 2026-09-28 | NCT05832229 | |
| Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2 | Aneurysm, aortic aneurysm, aortic disorder, cardiovascular disorder, thoracic aortic aneurysm, vascular disorder | Active, not recruiting | Not applicable | 2026-09-10 | NCT02777593 | |
| Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1 | Aneurysm, aortic aneurysm, aortic disorder, cardiovascular disorder, thoracic aortic aneurysm, vascular disorder | Active, not recruiting | Not applicable | 2026-09-10 | NCT02777528 | |
| Molecular Assessment and Profiling of Liver Transplant Recipients | Biomarkers; Liver Transplantation | Active, not recruiting | Not stated | 2026-09-03 | NCT04793360 | |
| Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms | Aneurysm, Aortic Aneurysm, Thoracoabdominal, abdominal aortic aneurysm, aortic aneurysm, aortic disorder, cardiovascular disorder, vascular disorder | Active, not recruiting | Not applicable | 2026-09-02 | NCT03728985 | |
| Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis | Active, not recruiting | Phase 3 | 2026-09-01 | NCT04526665 | |
| Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials | Stroke, Acute, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not stated | 2026-08-20 | NCT05338697 | |
| Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder | Active, not recruiting | Not applicable | 2026-06-24 | NCT01586910 | |
| Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH) | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Active, not recruiting | Not applicable | 2026-06-22 | NCT03838445 | |
| The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion | Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Pain, Signs and Symptoms | Recruiting | Phase 4 | 2026-05-01 | NCT05746143 | |
| IMPRoving Outcomes in Vascular DisEase - Aortic Dissection | Type B Aortic Dissection | Recruiting | Not applicable | 2026-04-29 | NCT06087029 | |
| Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial | brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Active, not recruiting | Not applicable | 2026-03-24 | NCT05478304 | |
| Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Diabetes Complications, Digestive System Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infant, Newborn, Diseases, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Urogenital Diseases, cystic fibrosis, cystic fibrosis-related diabetes, diabetes mellitus, endocrine system disorder, eye disorder, glucose metabolism disease, hereditary disease, kidney disorder, lung disorder, metabolic disease, pancreas disorder, peripheral neuropathy, respiratory system disorder, retinal disorder, urinary system disorder | Recruiting | Not stated | 2026-02-10 | NCT06837181 | |
| Smart Boot Use to Measure Offloading Adherence | Diabetes Complications, Diabetic Foot, Foot Ulcer, Leg Ulcer, Skin Ulcer, Skin and Connective Tissue Diseases, cardiovascular disorder, diabetes mellitus, diabetic neuropathy, diabetic peripheral angiopathy, endocrine system disorder, skin disorder, vascular disorder | Recruiting | Phase 2 | 2026-01-16 | NCT04460573 | |
| Liver Cirrhosis Network Cohort Study | Chemically-Induced Disorders, Cirrhosis, Cryptogenic, Digestive System Diseases, Fibrosis, Hepatitis, Chronic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, autoimmune disease, autoimmune hepatitis, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, fatty liver disease, hepatitis, immune system disorder, intrahepatic cholestasis, liver disorder, metabolic dysfunction-associated steatotic liver disease, primary biliary cholangitis, substance-related disorder | Active, not recruiting | Not stated | 2026-01-13 | NCT05740358 | |
| Reducing Lung CongestIon Symptoms in Advanced Heart Failure | cardiovascular disorder, heart disorder, heart failure | Active, not recruiting | Not applicable | 2025-08-19 | NCT03499236 | |
| Performance and Safety of Exufiber Ag+ and Exufiber on Partial Thickness Burns | Partial-thickness Burn | Active, not recruiting | Not applicable | 2024-11-12 | NCT04839523 |